Modulation of GABAA-receptors by honokiol and derivatives: Subtype selectivity and structure-activity relationship

Journal of Medicinal Chemistry

Volumn 54, Issue 15, 2011, Pages 5349-5361

  Taferner, Barbara ^a   Schuehly, Wolfgang ^b,c   Huefner, Antje ^b,d   Baburin, Igor ^a   Wiesner, Katharina ^a   Ecker, Gerhard F ^a   Hering, Steffen ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Institute of Pharmaceutical Sciences   (Austria)

^c Department of Pharmacognosy ^*  (Austria)

^d UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; CHLORIDE; HONOKIOL; 4 AMINOBUTYRIC ACID A RECEPTOR; BIPHENYL DERIVATIVE; LIGNAN;

ANIMAL CELL; ARTICLE; CHLORIDE CURRENT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROPHOBICITY; NEUROMODULATION; NONHUMAN; OOCYTE; PHARMACOPHORE; PROTEIN EXPRESSION; XENOPUS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; XENOPUS LAEVIS;

ANIMALS; BIPHENYL COMPOUNDS; LIGNANS; MODELS, MOLECULAR; OOCYTES; RECEPTORS, GABA-A; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 79961234552     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200186n     Document Type: Article

References (58)

1. Barnard, E. A.; Skolnick, P.; Olsen, R. W.; Mohler, H.; Sieghart, W.; Biggio, G.; Braestrup, C.; Bateson, A. N.; Langer, S. Z. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of subunit structure and receptor function Pharmacol. Rev. 1998, 50, 291-313 (Pubitemid 28304030)
2. Simon, J.; Wakimoto, H.; Fujita, N.; Lalande, M.; Barnard, E. A. Analysis of the set of GABA(A) receptor genes in the human genome J. Biol. Chem. 2004, 279, 41422-41435 (Pubitemid 39313583)
3. Olsen, R. W.; Sieghart, W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update Pharmacol. Rev. 2008, 60, 243-260
4. A channel subtypes Mol. Neurobiol. 1998, 18, 35-86 (Pubitemid 28501074)
5. Sieghart, W. Structure, pharmacology, and function of GABA(A) receptor subtypes Adv. Pharmacol. 2006, 54, 231-263
6. Mohler, H. GABA(A) receptor diversity and pharmacology Cell Tissue Res. 2006, 326, 505-516
7. Rudolph, U.; Crestani, F.; Mohler, H. GABA(A) receptor subtypes: dissecting their pharmacological functions Trends Pharmacol. Sci. 2001, 22, 188-194 (Pubitemid 32244305)
8. Wafford, K. A.; Bain, C. J.; Whiting, P. J.; Kemp, J. A. Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acid(A)/benzodiazepine receptors Mol. Pharmacol. 1993, 44, 437-442 (Pubitemid 23252252)
9. Wieland, H. A.; Luddens, H.; Seeburg, P. H. A single histidine in GABA(A) receptors is essential for benzodiazepine agonist binding J. Biol. Chem. 1992, 267, 1426-1429
10. Michael Kaplan, E.; DuPont, R. L. Benzodiazepines and anxiety disorders: a review for the practicing physician Curr. Med. Res. Opin. 2005, 21, 941-950
11. Whiting, P. J. GABA(A) receptors: a viable target for novel anxiolytics? Curr. Opin. Pharmacol. 2006, 6, 24-29 (Pubitemid 43103816)
12. Rupprecht, R.; Eser, D.; Zwanzger, P.; Moller, H. J. GABA(A) receptors as targets for novel anxiolytic drugs World J. Biol. Psychiatry 2006, 7, 231-237 (Pubitemid 44650532)
13. Butler, M. S. The role of natural product chemistry in drug discovery J. Nat. Prod. 2004, 67, 2141-2153 (Pubitemid 40092578)
14. Hajduk, P. J.; Bures, M.; Praestgaard, J.; Fesik, S. W. Privileged molecules for protein binding identified from NMR-based screening J. Med. Chem. 2000, 43, 3443-3447
15. A Receptor As a Novel Mode of Action of Lower-Chlorinated Non-Dioxin-Like PCBs Environ. Sci. Technol. 2010, 44, 2864-2869
16. A Receptors Expressed in Xenopus Oocytes Biosci., Biotechnol., Biochem. 2001, 65, 2070-2077 (Pubitemid 33667827)
17. Hui, K. M.; Huen, M. S.; Wang, H. Y.; Zheng, H.; Sigel, E.; Baur, R.; Ren, H.; Li, Z. W.; Wong, J. T.; Xue, H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi Biochem. Pharmacol. 2002, 64, 1415-1424 (Pubitemid 35248258)
18. Marder, M.; Viola, H.; Wasowski, C.; Fernandez, S.; Medina, J. H.; Paladini, A. C. 6-Methylapigenin and hesperidin: new Valeriana flavonoids with activity on the CNS Pharmacol., Biochem. Behav. 2003, 75, 537-545 (Pubitemid 36936888)
19. Baur, R.; Simmen, U.; Senn, M.; Sequin, U.; Sigel, E. Novel plant substances acting as beta subunit isoform-selective positive allosteric modulators of GABA(A) receptors Mol. Pharmacol. 2005, 68, 787-792 (Pubitemid 41206033)
20. Khom, S.; Baburin, I.; Timin, E.; Hohaus, A.; Trauner, G.; Kopp, B.; Hering, S. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity Neuropharmacology 2007, 53, 178-187 (Pubitemid 47125958)
21. Schühly, W.; Khan, I.; Fischer, N. H. The Ethnomedicinal Uses of Magnoliaceae from the Southeastern United States as Leads in Drug Discovery Pharm. Biol. 2001, 39, 63-69
22. Toriizuka, K. Traditional Medicine and Magnolia. In Magnolia-The Genus Magnolia; Sarker, S. D.; Maruyama, Y., Eds.; Taylor & Francis: London, 2002.
23. Maruyama, Y.; Kuribara, H. Overview of the Pharmacological Features of Honokiol CNS Drug Rev. 2000, 6, 35-44 (Pubitemid 30179968)
24. Maruyama, Y.; Ikarashi, Y.; Kuribara, H. Bioactivity and pharmacological aspects of Magnolia. In Magnolia-The Genus Magnolia; Sarker, S. D.; Maruyama, Y., Eds.; Taylor & Francis: London, 2002; pp 75-128.
25. Schühly, W.; Khan, S. I.; Fischer, N. H. Neolignans from North American Magnolia species with cyclooxygenase 2 inhibitory activity Inflammopharmacology 2009, 17, 106-110
26. Kuribara, H.; Kishi, E.; Hattori, N.; Okada, M.; Maruyama, Y. The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from Magnolia bark J. Pharm. Pharmacol. 2000, 52, 1425-1429
27. Kuribara, H.; Kishi, E.; Kimura, M.; Weintraub, S. T.; Maruyama, Y. Comparative assessment of the anxiolytic-like activities of honokiol and derivatives Pharmacol. Biochem. Behav. 2000, 67, 597-601 (Pubitemid 32103571)
28. Kuribara, H.; Stavinoha, W. B.; Maruyama, Y. Honokiol, a putative anxiolytic agent extracted from Magnolia bark, has no diazepam-like side-effects in mice J. Pharm. Pharmacol. 1999, 51, 97-103 (Pubitemid 29097276)
29. Watanabe, K.; Watanabe, H.; Goto, Y.; Yamaguchi, M.; Yamamoto, N.; Hagino, K. Pharmacological Properties of Magnolol and Honokiol Extracted from Magnolia officinalis: Central Depressant Effects Planta Med. 1983, 49, 103-108 (Pubitemid 14239052)
30. Xu, Q.; Yi, L. T.; Pan, Y.; Wang, X.; Li, Y. C.; Li, J. M.; Wang, C. P.; Kong, L. D. Antidepressant-like effects of the mixture of honokiol and magnolol from the bark of Magnolia officinalis in stressed rodents Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 715-725 (Pubitemid 351312371)
31. Ai, J.; Wang, X.; Nielsen, M. Honokiol and magnolol selectively interact with GABA(A) receptor subtypes in vitro Pharmacology 2001, 63, 34-41 (Pubitemid 32623459)
32. Ma, H.; Jo, Y. J.; Ma, Y.; Hong, J. T.; Kwon, B. M.; Oh, K. W. Obovatol isolated from Magnolia obovata enhances pentobarbital-induced sleeping time: possible involvement of GABA(A) receptors/chloride channel activation Phytomedicine 2009, 16, 308-313
33. Fukuyama, Y.; Nakade, K.; Minoshima, Y.; Yokoyama, R.; Zhai, H.; Mitsumoto, Y. Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons Bioorg. Med. Chem. Lett. 2002, 12, 1163-1166 (Pubitemid 34270554)
34. Liou, K. T.; Shen, Y. C.; Chen, C. F.; Tsao, C. M.; Tsai, S. K. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production Brain Res. 2003, 992, 159-166
35. Maruyama, Y.; Kuribara, H.; Morita, M.; Yuzurihara, M.; Weintraub, S. T. Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine J. Nat. Prod. 1998, 61, 135-138 (Pubitemid 28086994)
36. Squires, R. F.; Ai, J.; Witt, M. R.; Kahnberg, P.; Saederup, E.; Sterner, O.; Nielsen, M. Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites Neurochem. Res. 1999, 24, 1593-1602
37. Schühly, W.; Hüfner, A.; Pferschy-Wenzig, E. M.; Prettner, E.; Adams, M.; Bodensieck, A.; Kunert, O.; Oluwemimo, A.; Haslinger, E.; Bauer, R. Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase- mediated LTB4-formation Bioorg. Med. Chem. 2009, 17, 4459-4465
38. Johnson, D. V.; Griengl, H. The chemoenzymatic synthesis of (S)-13-hydroxyoctadeca-(9 Z,11 E)-dienoic acid using the hydroxynitrile lyase from Hevea brasiliensis Tetrahedron 1997, 53, 617-624 (Pubitemid 26423006)
39. Tietze, L. F.; Eicher, T. Reaktionen und Synthesen im Organisch-Chemischen Praktikum und Forschungslaboratorium, 2nd ed.; Georg Thieme Verlag: Stuttgart, New York, 1991; pp 201-210.
40. Ray, R.; Matteson, D. S. Osmium tetroxide catalyzed hydroxylation of hindered olefins Tetrahedron Lett. 1980, 21, 449-450
41. 2 receptor inverse agonists Chem. Biol. 2011, DOI: 10.1016/j.chembiol.2011.05.012.
42. Chattopadhyay, S. K.; Biswas, T.; Maity, S. Sequential double Claisen rearrangement and two-directional ring-closing metathesis as a route to various benzofused bisoxepin and bisoxocin derivatives Synlett 2006, 14, 2211-2214 (Pubitemid 44393523)
43. Brown, H. C.; Kurek, J. T. The Solvomercuration-Demercuration of Representative Olefins in the Presence of Acetonitrile. A Convenient Procedure for the Synthesis of Amines J. Am. Chem. Soc. 1969, 91, 5647-5649
44. Muathen, H. N. Selective Nitration of Aromatic Compounds with Bismuth Subnitrate and Thionyl Chloride Molecules 2003, 8, 593-598
45. Johnson, T. W.; Corey, E. J. Enantiospecific synthesis of the proposed structure of the antitubercular marine diterpenoid pseudopteroxazole: revision of stereochemistry J. Am. Chem. Soc. 2001, 123, 4475-4479 (Pubitemid 32923375)
46. Widdowson, K. L.; Elliott, J. D.; Veber, D. F.; Nie, H.; Rutledge, M. C.; McCleland, B. W.; Xiang, J. N.; Jurewicz, A. J.; Hertzberg, R. P.; Foley, J. J.; Griswold, D. E.; Martin, L.; Lee, J. M.; White, J. R.; Sarau, H. M. Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor J. Med. Chem. 2004, 47, 1319-1321 (Pubitemid 38327458)
47. Yamamoto, T.; Hori, M.; Watanabe, I.; Tsutsui, H.; Ikeda, S.; Ohtaka, H. An acid-catalyzed O, N -acyl migration and application to the synthesis of N -(4-isopropyl-2,2-dimethyl-3-oxo-3,4-dihydro-2 H -benzo[1,4]oxazine-6-carbonyl) guanidine methanesulfonate (KB-R9032), a novel Na/H exchange inhibitor Chem. Pharm. Bull. 1999, 47, 22-27 (Pubitemid 29078727)
48. Eicher, T.; Roth, H. J. Synthese, Gewinnung und Charakterisierung von Arzneistoffen.: Georg Thieme Verlag: Stuttgart, New York, 1986; p 35.
49. Khom, S.; Baburin, I.; Timin, E. N.; Hohaus, A.; Sieghart, W.; Hering, S. Pharmacological properties of GABA(A) receptors containing gamma1 subunits Mol. Pharmacol. 2006, 69, 640-649 (Pubitemid 43121961)
50. Baburin, I.; Beyl, S.; Hering, S. Automated fast perfusion of Xenopus oocytes for drug screening Pflugers Arch. 2006, 453, 117-123 (Pubitemid 44454892)
51. Bai, X.; Cerimele, F.; Ushio-Fukai, M.; Waqas, M.; Campbell, P. M.; Govindarajan, B.; Der, C. J.; Battle, T.; Frank, D. A.; Ye, K.; Murad, E.; Dubiel, W.; Soff, G.; Arbiser, J. L. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo J. Biol. Chem. 2003, 278, 35501-35507 (Pubitemid 37102321)
52. Ikeda, K.; Nagase, H. Magnolol has the ability to induce apoptosis in tumor cells Biol. Pharm. Bull. 2002, 25, 1546-1549 (Pubitemid 39663667)
53. Ikeda, K.; Sakai, Y.; Nagase, H. Inhibitory effect of magnolol on tumour metastasis in mice Phytother. Res. 2003, 17, 933-937 (Pubitemid 37152762)
54. Syu, W. J.; Shen, C. C.; Lu, J. J.; Lee, G. H.; Sun, C. M. Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis Chem. Biodivers. 2004, 1, 530-537
55. Walters, R. J.; Hadley, S. H.; Morris, K. D. W.; Amin, J. Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms Nature Neurosci. 2000, 3, 1274-1281
56. Johnston, G. A. R.; Hanrahan, J. R.; Chebib, M.; Duke, R. K.; Mewett, K. N. Modulation of Ionotropic GABA receptors by natural products of plant origin Adv. Pharmacol. 2006, 54, 285-316
57. Mohler, H.; Fritschy, J. M.; Crestani, F.; Hensch, T.; Rudolph, U. Specific GABA(A) circuits in brain development and therapy Biochem. Pharmacol. 2004, 68, 1685-1690 (Pubitemid 39286473)
58. El-Feraly, F. S.; Chan, Y. M. Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L J. Pharm. Sci. 1978, 67, 347-350 (Pubitemid 8297782)